Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure

Fertil Steril. 2006 Oct;86(4):1009-12. doi: 10.1016/j.fertnstert.2006.02.107.

Abstract

Mutational screening of the bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9) genes in a population with premature ovarian failure (POF) identified no new mutations. However, three single nucleotide polymorphisms in the BMP15 gene, two in the 5' untranslated region (31T>G and 71C>G) and another in exon 1 (387G>A), were found to be common in both POF and control groups.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bone Morphogenetic Protein 15
  • DNA Mutational Analysis
  • Female
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Predisposition to Disease / genetics
  • Genetic Testing / methods*
  • Growth Differentiation Factor 9
  • Humans
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Mutation
  • New Zealand / epidemiology
  • Prevalence
  • Primary Ovarian Insufficiency / epidemiology*
  • Primary Ovarian Insufficiency / genetics*
  • Risk Assessment / methods*
  • Risk Factors

Substances

  • BMP15 protein, human
  • Bone Morphogenetic Protein 15
  • GDF9 protein, human
  • Growth Differentiation Factor 9
  • Intercellular Signaling Peptides and Proteins